Surface Tension and Intrinsic Amyloid Fluorescence of Serum and Cerebrospinal Fluid Samples in Alzheimer´S Disease

References

• Zaitsev S . Dynamic surface tension measurements as general approach to the analysis of animal blood plasma and serum. Adv. Colloid Interface Sci.235, 201–213 (2016).
   PubMed Web of Science ®Google Scholar
• Kazakov VN , VozianovAF, SinyachenkoOV, TrukhinDV, KovalchukVI, PisonU. Studies on the application of dynamic surface tensiometry of serum and cerebrospinal liquid for diagnostics and monitoring of treatment in patients who have rheumatic, neurological or oncological diseases. Adv. Colloid Interface Sci.86 (1–2), 1–38 (2000).
   PubMed Web of Science ®Google Scholar
• Fathi-Azarbayjani A , JouybanA. Surface tension in human pathophysiology and its application as a medical diagnostic tool. Bioimpacts5 (1), 29–44 (2015).
   PubMedGoogle Scholar
• Wilfang J , LewczukP, RiedererPet al. Consensus paper of the WFSBP task force on biological markers of dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementia. World J. Biol. Psych.6 (2), 69–84 (2005).
   PubMed Web of Science ®Google Scholar
• Mottaghy K , HahnA. Interfactial tension of some biological fluids: a comparative study. J. Clin. Chem. Clin. Biochem.19 (5), 267–271 (1981).
   PubMedGoogle Scholar
• Lin TY , TimasheffSN. On the role of surface tension in the stablilization of globular proteins. Protein Sci.5 (2), 372–381 (1996).
   PubMed Web of Science ®Google Scholar
• Chichili VPR , KumarV, SivarramanJ. Linkers in the structural biology of protein–protein interactions. Protein Sci.22 (2), 153–167 (2012).
   Web of Science ®Google Scholar
• Schuster T , KrumpferJW, SchellenbergerS, FriedrichR, KlapperM, MüllenK. Effects of chemical structure on the dynamic and static surface tensions of short-chain, multi-arm nonionic fluorosurfactants. J. Colloid Interface Sci.428, 276–285 (2014).
   PubMed Web of Science ®Google Scholar
• Soreghan B , KosmoskiJ, GlabeC. Surfactant properties of Alzheimer´s A beta peptides and the mechanism of amyloid aggregation. J. Biol. Chem.269 (46), 28551–28554 (1994).
   PubMed Web of Science ®Google Scholar
• Ambroggio EE , KimDH, SeparovicFet al. Surface behavior and lipid interaction of Alzheimer β-amyloid peptide 1-42: a membrane-disrupting peptide. Biophys. J.88 (4), 2706–2713 (2005).
   PubMed Web of Science ®Google Scholar
• Williams TL , SerpellLC. Membrane and surface interactions of Alzheimer´s Aβ peptide – insights into the mechanism of cytotoxicity. FEBS J.278 (20), 3905–3917 (2011).
   PubMed Web of Science ®Google Scholar
• Brydon HL , HaywardR, Harkness Wand BaystonR. Physical properties of cerebrospinal fluid of relevance to shunt function. 2: the effect of protein upon CSF surface tension and contact angle. Br. J. Neurosurg.9 (5), 645–651 (1995).
   PubMed Web of Science ®Google Scholar
• Sun X , WuWH, LiuQet al. Hybrid peptides attenuate cytotoxicity of β-amyloid by inhibiting its oligomerization: implication from solvent effects. Peptides30 (7), 1282–1287 (2009).
   PubMed Web of Science ®Google Scholar
• Kachooei E , Moosavi-MovahediAA, KhodagholiF, RamshiniH, ShaerzadehF, SheibaniN. Oligomeric forms of insulin amyloid aggregation disrupt ourgrowth and complexity of neuron-like PC12 cells. PLoS ONE7 (7), e41344 (2012).
   PubMed Web of Science ®Google Scholar
• Ruiz ED , AlmadaM, BurboaMGet al. Oligomers, protofibrils and amyloid fibrils from recombinant human lysozyme (rHL): fibrillation process and cytotoxicity evaluation for ARPE-19 cell line. Colloid. Surf. B-Biointerfaces126, 335–343 (2015).
   PubMed Web of Science ®Google Scholar
• Maji SK , AmsdenJJ, RothschildKJ, CondronMM, TeplowDB. Conformational dynamics of amyloid β-protein assembly probed using intrinsic fluorescence. Biochemistry44 (40), 13365–13376 (2005).
   PubMed Web of Science ®Google Scholar
• Chan FTS , Kaminski SchierleGS, KumitaJR, BertonciniCW, DobsonCM, KaminskuCF. Protein amyloids develop an intrinsic fluorescence signature during aggregation. Analyst138 (7), 2156–2162 (2013).
   PubMed Web of Science ®Google Scholar
• Groenning M . Binding mode of Thioflavin T and other molecular probes in the context of amyloid fibrils – current status. J. Chem. Biol.3 (1), 1–8 (2010).
   PubMedGoogle Scholar
• Maezawa I , HongHAS, LiuRet al. Congo red and thioflavin-T analogs detect Aβ oligomers. J. Neurochem.104 (2), 457–468 (2008).
   PubMed Web of Science ®Google Scholar
• Kristofikova Z , GazovaZ, SiposovaKet al. Effects of ferrofluid and phytoalexin spirobrassinin on Thioflavin-T-based fluorescence in cerebrospinal fluid of the elderly and multiple sclerosis patients. Neurochem. Res.39 (8), 1502–1510 (2014).
   PubMed Web of Science ®Google Scholar
• Gazova Z , AntosovaA, KristofikovaZet al. Attenuated antiaggregation effects of magnetite nanoparticles in cerebrospinal fluid of people with Alzheimer´s disease. Mol. Biosyst.6 (11), 2200–2205 (2010).
   PubMedGoogle Scholar
• Sitkiewicz E , OledzkiJ, PoznanskiJ, DadlezM. Di-tyrosine cross-link decreases the collisional cross-section of Ab peptide dimers and trimers in the gas phase: an ion mobility study. PloS ONE9 (6), e100200 (2014).
   PubMed Web of Science ®Google Scholar
• Folstein MF , FolsteinSE, McHughPR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res.12 (3), 189–198 (1975).
   PubMed Web of Science ®Google Scholar
• Mioshi E , DawsonK, MitchellJ, ArnoldT, HodgesJR. The Addenbrooke´s Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int. J. Geriatr. Psychiatry21 (11), 1078–1085 (2006).
   PubMed Web of Science ®Google Scholar
• Bartos A , RaisovaM. The Mini-Mental State Examination: Czech norms and cutoffs for mild dementia and mild cognitive impairment due to Alzheimer´s disease. Dement. Geriatr. Cogn. Disord.42 (1-2), 50–57 (2016).
   PubMed Web of Science ®Google Scholar
• Deisenhammer F , BartosA, EggRet al. Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force. Eur. J. Neurol.13 (9), 913–922 (2006).
   PubMed Web of Science ®Google Scholar
• Hort J , BartosA, PirttiläT, ScheltensP. Use of cerebrospinal fluid biomarkers in diagnosis of dementia across Europe. Eur. J. Neurol.17 (1), 90–96 (2010).
   PubMed Web of Science ®Google Scholar
• Albert MS , DeKoskyST, DicksonDet al. The diagnosis of mild cognitive impairment due to Alzheimer´s disease: recommendations from the National Institute on Aging-Alzheimer´s Association workgroups on diagnostic guidelines for Alzheimer´s disease. Alzheimers Dement.7 (3), 270–279 (2011).
   PubMed Web of Science ®Google Scholar
• McKhann GM , KnopmanDS, ChertkowHet al. The diagnosis of dementia due to Alzheimer´s disease: recommendations from the National Institute on Aging-Alzheimer´s Association workgroups on diagnostic guidelines for Alzheimer´s disease. Alzheimers Dement.7 (3), 263–269 (2011).
   PubMed Web of Science ®Google Scholar
• Sheskin DJ . Measures of association/correlation. In Handbook of Parametric and Nonparametric Statistical Procedures (5th Edition). Chapman and Hall/CRC, New York, USA, 1219–1413 (2011).
   Google Scholar
• Schoonjans F . ROC curve analysis. InMedCalc Manual.MedCals Software bvba, Ostend, Belgium, 177–190 (2014).
   Google Scholar
• Kristofikova Z , RipovaD, BartosAet al. Neuroinflammation and complexes of 17β-hydroxysteroid dehydrogenase type 10 - amyloid β in Alzheimer´s disease. Curr. Alzeimer Res.10 (2), 165–173 (2013).
   PubMed Web of Science ®Google Scholar
• Kristofikova Z , RicnyJ, KolarovaMet al. Interactions between amyloid-β and tau in cerebrospinal fluid of people with mild cognitive impairment and Alzheimer´s disease. J. Alzheimers Dis.42 (suppl. 3), S91–S98 (2014).
   PubMedGoogle Scholar
• Kristofikova Z , RicnyJ, VyhnalekMet al. Levels of 17β-hydroxysteroid dehydrogenase type 10 in cerebrospinal fluid of people with mild cognitive impaiment and various types of dementia. J. Alzheimers Dis.48 (1), 105–114 (2015).
   PubMed Web of Science ®Google Scholar
• Kolarova M , SenguptaU, BartosA, RicnyJ, KayedR. Tau oligomers in sera of patients with Alzheimer´s disease and aged controls. J. Alzheimers Dis.58 (2), 471–478 (2017).
   PubMed Web of Science ®Google Scholar
• Gong Y , ChangL, ViolaKLet al. Alzheimer´s disease-affected brain: presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc. Natl Acad. Sci. USA100 (18), 10417–10422 (2003).
   PubMed Web of Science ®Google Scholar
• Olsson B , LautnerR, AndreassonUet al. CSF and blood biomarkers for the diagnosis of Alzheimer´s disease: a systematic review and meta-analysis. Lancet Neurol.15 (7), 673–684 (2016).
   PubMed Web of Science ®Google Scholar
• Wu HZ , OngKL, SeeherKet al. Circulating microRNAs as biomarkers of Alzheimer´s disease: a systematic review. J. Alzheimers Dis.49 (3), 755–766 (2016).
   PubMed Web of Science ®Google Scholar
• Wojsiat J , Laskowska-KaszubK, Mietelska-PorowkaA, WojdaU. Search for Alzheimer´s disease biomarkers in blood cells: hypotheses-driven approach. Biomark. Med.11 (10), 917–931 (2017).
   PubMed Web of Science ®Google Scholar
• Hartmann S , Ledur KistTB. A review of biomarkers of Alzheimer´s disease in noninvasive samples. Biomark. Med.12 (6), 677–690 (2018).
   PubMed Web of Science ®Google Scholar